Stocks
GlaxoSmithKline (GSK) Assets US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Assets, £ | 107 141 058 350 | 60 146 000 000 | 75 219 574 000 | 59 463 000 000 | 61 010 573 000 | 82 905 350 000 | |||
| Changes by years, y/y, % | -3% | -44% | +25% | -21% | +3% | -11.1% | |||
GlaxoSmithKline. Assets, £
GlaxoSmithKline. Assets, changes, %
GlaxoSmithKline (GSK) Assets US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Assets, £ | 78 354 978 750 | 81 204 200 300 | 82 577 629 000 | 61 010 573 000 | 82 905 350 000 | 82 905 350 000 | ||
| Changes by years, y/y, % | +6% | +11% | +42% | +3% | +6% | |||
| Changes by quarters, q/q, % | +32% | +4% | +2% | -26% | +36% | |||
